C3 glomerulopathy (C3G) is a rare and progressive complement-mediated kidney disease (CMKD). Its pathogenesis is complex; however, innovative therapies designed to target specific points within the complement pathway are under development. Given the rapidly evolving treatment landscape for CMKDs, it is critical to stay up to date on the latest clinical data for these agents. In this interactive Booster Quiz, don’t miss the opportunity to: Check your understanding of the complex pathophysiology and biomarkers associated with C3G Test your knowledge of the latest clinical evidence on emerging therapies for C3G Get instant feedback on your answer selections See how well you do relative to other healthcare professionals
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/rfp-response-complement-mediated-kidney-diseases-c3g-ahus-ic-mpgn-preparing
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 44916.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest